请用 Wechat 扫描台湾精品QRcode 或 搜寻ID: TaiwanExcellence
Beranda / Penghargaan Taiwan Excellence / Award Winning Products / Product Details
AmCAD-CA
Jenis industri：Komputer dan Software
Kode produk：1
AmCad BioMed Corporation
AmCAD-CA adalah perangkat lunak yang dirancang untuk menganalisis gambar sitologi (sel cairan tubuh manusia) secara digital. Selain penyesuaian perubahan morfologi dan teknik kromatologi, AmCAD-CA dapat digunakan untuk mengidentifikasi karakteristik sitologi seperti rasio inti sel (nucleus) dan sitoplasma (cytoplasm), perbedaan ukuran dan bentuk inti sel (anisokaryosis), kesesuaian inti sel yang berdekatan satu sama lain (nuclear molding), invaginasi sitoplasma ke dalam nukleus (pseudoinclusion), dll. Data kuantitatif numerik dan visualisasi sitologi dapat digunakan untuk membantu interpretasi klinis penyakit. Secara itu, komputer medis computer-aided diagnosis (CAD) telah disertakan dalam perangkat lunak ini untuk membantu diagnosis kanker tiroid (thyroid neoplasm).
Fitur Produk:
1. Klasifikasi otomatis sitoplasma (cytoplasm) dan inti sel (nucleus)
2. Data yang divisualisasikan dan dikuantifikasi untuk analisis statistik lebih lanjut
3. Identifikasi karakteristik sitologi, perubahan morfologi dan teknik kromatologi
4. Interpretasi diagnosis perkiraan risiko keganasan kanker tiroid
5. Mendukung pengambilan gambar digital secara real-time dari kamera mikroskop untuk menganalisis dan menginterpretasi langsung, misalnya dari sampel smear sitologi
Tentang kami AmCad BioMed Corporation
AmCad BioMed Corporation (AmCad) was founded in 2008 and was listed on Taipei Exchange in the March of 2015 (Ticker: 4188). Our breadth of expertise, from R&D to commercialization, have resulted in world’s first FDA cleared ultrasound Computer-Assisted Detection (CAD) devices. AmCad is committed to assisting medical professionals in making efficient and accurate diagnosis through the support of detailed sonographic visualization and quantification. By integrating AI technology with clinicians' expertise, AmCad will continue to pioneer best-in-class imaging solutions that anticipate mainstream medical needs.
When it comes to ultrasound examination for thyroid, different physicians may arrive at different interpretations over the same image; the inconsistency of the results may reach up to 70%. Even though physicians made a definitive diagnosis and thus performed thyroidectomy, up to 50% of results turned out to be benign. Unfortunately, life-long medication is required for patients who have undergone thyroidectomy.
A reliable approach is needed for the physicians to make faster and more effective interpretations and thus avoid unnecessary thyroidectomy.
AmCAD-UT utilizes patented image analysis technology to capture clinical diagnostic features of thyroid neoplasm from 2D ultrasound images. Through quantification and visualization, detailed color images are thereby displayed for substantially improved and more accurate medical ultrasound interpretation.
Informasi kontak